Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Alzheimer's vaccine steps closer with new study
A new vaccine combination has proven successful in mouse models of Alzheimer's, new study reveals, and it could be tested in humans within 3-5 years.
Moffitt Cancer Center launches nationwide e-cigarette study
The research study seeks 2,500 adult smokers who use both cigarettes and e-cigarettes.The use of electronic cigarettes ("e-cigarettes") has increased dramatically in recent years.
Prostate cancer: Unexpected results from international Phase III study
A recently published international clinical Phase III trial of a promising drug for treating advanced prostate cancer ended with surprising results: the new therapeutic agent failed to achieve any...
International collaboration to create new cancer models to accelerate research
An international project to develop a large, globally accessible, bank of new cancer cell culture models for the research community launches today (Monday).
Colorectal cancer: Pivotal Phase III data for Xilonix presented
XBiotech Inc., developer of next-generation True Human™ antibody therapies, has presented positive results from a pivotal Phase III trial of Xilonix™, the company's lead monoclonal...
Pancreatic cancer survival could be increased with new treatment combo
In mice with pancreatic cancer, researchers found adding an investigational drug to immunotherapy and chemotherapy more than tripled their survival.
Regorafenib shows significant survival gains in refractory liver cancer
Phase III trial confirms efficacy and safety of new second-line agent.Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with...
Pluristem reports data showing PLX-PAD cells effective in treating Duchenne muscular dystrophy
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne...
Brain training video games in ground-breaking clinical trial to tackle cognitive impairment in people with Parkinson's
MyCognition, a leading cognitive assessment and training company, has announced it is launching a ground-breaking clinical trial, addressing the cognitive impact of Parkinson's disease, led by...
Multi-centre trial to test new treatment for chronic cough
A clinical trial to test a promising new treatment for chronic cough that could lead to the first new cough drug in 50 years has been launched by the National Institute for Health Research.
Diabetes: Faster-acting insulin aspart vs NovoRapid results
Full results from onset 1 and onset 2 - the phase 3a trials assessing the use of faster-acting insulin aspart in people with type 1 diabetes (onset 1) and type 2 diabetes (onset 2) - were presented...
Erenumab significantly reduces patients' monthly migraine days in Phase 2 study for the prevention of chronic migraine
Amgen has announced positive top-line results from the global Phase 2 study evaluating the efficacy and safety of erenumab (AMG 334) in chronic migraine prevention.
Investigational immunotherapy drug well tolerated in those with rare form of melanoma
An investigational immunotherapy drug being tested in the treatment of a rare form of skin cancer known as Merkel cell carcinoma has been found to be well tolerated with a clinical benefit seen in...
Pembrolizumab elicits significant antitumor activity in head and neck cancer patients
Treating head and neck cancer patients with recurrent or metastatic disease with the PD-1 inhibitor pembrolizumab resulted in significant clinical responses in a fifth of the patients from a phase...
Lenalidomide maintenance therapy improves overall survival for patients with multiple myeloma
While several clinical trials have demonstrated that maintenance therapy with lenalidomide reduces the risk of disease progression in patients with multiple myeloma, there have been no definitive...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2016
Content Management / Website Design by Tresware